List of SBIR/STTR awards granted to ImmunoChem Therapeutics, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to ImmunoChem Therapeutics, LLC in September, 2021 for $450,367.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG071062-01A1 | Phase I | 450,367 | September 1, 2021 | |||||||
A SBIR Phase I contract was awarded to ImmunoChem Therapeutics, LLC in September, 2018 for $499,320.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG060846-01 | Phase I | 499,320 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to ImmunoChem Therapeutics, LLC in September, 2019 for $1,157,853.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG060846-02 | Phase II | 1,157,853 | September 15, 2019 | |||||||
A SBIR Phase II contract was awarded to ImmunoChem Therapeutics, LLC in August, 2021 for $777,049.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA236382-02 | Phase II | 777,049 | August 1, 2021 | |||||||
A STTR Phase I contract was awarded to ImmunoChem Therapeutics, LLC in May, 2019 for $224,888.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42CA236382-01 | Phase I | 224,888 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to ImmunoChem Therapeutics, LLC in September, 2022 for $498,363.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS124443-01A1 | Phase I | 498,363 | September 18, 2022 |
